Facebook Twitter RSS Feed

You are here

 - Washington

The Transcatheter Cardiovascular Therapeutics (TCT) conference announced its lineup for late-breaking clinical trials and first report investigations that will be a presented Sept. 13-15 at the scientific sessions in Washington, D.C.

 - No radiation

Wearing a bleeper device during catheterizations helped lower radiation exposure to operators by about one third in the RadiCure Study. Results from the late-breaking randomized controlled clinical trial were presented May 30 at the Society for Cardiovascular Angiography and Interventions (SCAI) scientific session in Las Vegas.

 - Diamondback handle

Significant per-patient savings and better outcomes may be possible with an atherectomy device presented as a late-breaking clinical trial May 30 at the Society for Cardiovascular Angiography and Interventions (SCAI) scientific session in Las Vegas. Compared with Medicare patients, ORBIT II patients saw a cost reduction of over $2,500 per patient and a shorter hospital stay by up to three days.

 - electrical shock, ICD shock

ACE inhibitors and ARBs have a protective effect on patients with cardiomyopathy who receive implantable cardioverter-defibrillators (ICDs), according to an analysis presented May 8 at the Heart Rhythm Society scientific session in San Francisco.

 - ecg, heart, electrophysiology

The longevity of some implantable cardiac devices can vary greatly by manufacturer, according to a Danish study presented May 8 at the Heart Rhythm Society scientific session in San Francisco. The study showed Medtronic with the highest rate of battery depletion or device failure.